Elevai Labs, Inc. (NASDAQ:ELAB) Short Interest Down 44.6% in February

Elevai Labs, Inc. (NASDAQ:ELAB) was the recipient of a significant decline in short interest in the month of February. As of February 15th, there was short interest totalling 185,700 shares, a decline of 44.6% from the January 31st total of 335,000 shares. Based on an average daily volume of 2,210,000 shares, the days-to-cover ratio is currently 0.1 days.

Elevai Labs Trading Down 2.8 %

NASDAQ ELAB opened at $1.21 on Tuesday. The company has a current ratio of 3.86, a quick ratio of 3.40 and a debt-to-equity ratio of 0.06. The stock has a market cap of $4.89 million, a PE ratio of -0.02 and a beta of -3.28. The company’s 50-day moving average price is $1.97 and its 200-day moving average price is $16.58. Elevai Labs has a 12 month low of $1.16 and a 12 month high of $165.96.

About Elevai Labs

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.